Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant.
about
Epithelial V-like antigen (EVA), a novel member of the immunoglobulin superfamily, expressed in embryonic epithelia with a potential role as homotypic adhesion molecule in thymus histogenesisB cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung diseaseDendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to miceExtending the CD4(+) T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar typhimurium delivery vehicle.Prevention of arthritis by interleukin 10-producing B cells.Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice.Dendritic cell-based vaccines: barriers and opportunitiesType I IFN-dependent T cell activation is mediated by IFN-dependent dendritic cell OX40 ligand expression and is independent of T cell IFNR expression.CD11c-Expressing B Cells Are Located at the T Cell/B Cell Border in Spleen and Are Potent APCsDendritic cell maturation and antigen presentation in the absence of invariant chain.Right place, right time, right peptide: DO keeps DM focused.Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.CD4+ T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cellsInterleukin 4-producing CD4 T cells arise from different precursors depending on the conditions of antigen exposure in vivo.High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes.Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro.Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen.T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice.What can transgenic parasites tell us about the development of Plasmodium-specific immune responses?Peripheral CD4(+) T-cell tolerance is induced in vivo by rare antigen-bearing B cells in follicular, marginal zone, and B-1 subsetsMechanisms of action of adjuvantsAdjuvants in micro- to nanoscale: current state and future direction.Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii.B cells and antibodies are required for resistance to the parasitic gastrointestinal nematode Trichuris muris.Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infection.Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO.Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice.Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells.Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component.
P2860
Q24315853-BF4D0B37-DF09-4665-B893-B40C2C391BA5Q33366487-09148C11-5754-4C93-9256-379E17EED232Q33784661-0D27D9CA-DF93-4FA3-ABDD-BC60AE3FDEB9Q34004518-02725956-5BE5-441E-AD25-A34521331C34Q34178104-1659AD56-A258-40DA-8204-794BE5FED9C7Q34353473-1E68D45C-D426-4347-8E61-AD77EC8A4FC5Q34411828-FD3E556A-7E0F-49E2-B9F1-A93BD1765EA3Q34661797-89ADA8F6-BF1E-4A10-BF96-344B480FD571Q35658873-DB895943-3211-4B45-AF1A-C85DAD08288AQ35762700-39DA36FD-6A7B-4CFA-B450-767E992CCC27Q35789511-D9A5EC7A-197F-453D-B661-C66489E9D036Q36266508-2A879E3D-AA68-4652-801D-0539B735FBE9Q36367948-C999973E-2B7E-4F6F-9390-0631728FB89DQ36371288-252E86F6-4098-4945-9D6F-0F3ADDAC5DEAQ36375967-9772714E-E6BB-4915-80D6-3DFB5C27BAE1Q36380488-36380F4D-28FA-49C8-AB2C-8A60E8E99272Q36380500-ACF458CB-60E6-4871-80E9-186E1D35B59EQ36438020-4CD4550B-46F9-4F78-87CE-361F681748BAQ36757834-7307EA9C-F854-409E-AC12-064083F2F258Q36823006-D27BC36B-0BBD-4761-9BAF-208722DA5902Q37103943-E2E8B102-72B6-4944-BE19-46165527F696Q37352206-8D8EE452-90C9-4DDE-87B8-3630E2C1F654Q38110539-A537EB06-1842-4450-A97B-1D213130E151Q38520210-9CDA2345-2D01-45E7-8533-14B0587831FEQ39514978-64D31E42-2002-4FD2-B299-15D0DBEE5537Q39520679-C197E093-6D55-47F9-867B-8A6AEE535761Q39521012-82531EB5-568C-4CD3-925C-2725F4B53349Q40737770-C8746879-5C02-4822-86C0-0A4EA9B2F3B7Q40894562-F6E00CC3-0CBF-45E8-8532-12017BE4E681Q41029994-70B89F00-6C6E-4DB7-B27B-B6B158124B96Q41839042-83FCF212-1623-4FC5-9784-B977A516C015
P2860
Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Dendritic cells but not B cell ...... ration of protein in adjuvant.
@ast
Dendritic cells but not B cell ...... ration of protein in adjuvant.
@en
type
label
Dendritic cells but not B cell ...... ration of protein in adjuvant.
@ast
Dendritic cells but not B cell ...... ration of protein in adjuvant.
@en
prefLabel
Dendritic cells but not B cell ...... ration of protein in adjuvant.
@ast
Dendritic cells but not B cell ...... ration of protein in adjuvant.
@en
P2093
P2860
P356
P1476
Dendritic cells but not B cell ...... ration of protein in adjuvant.
@en
P2093
P2860
P304
P356
10.1084/JEM.183.3.751
P407
P577
1996-03-01T00:00:00Z